KRAS and non-small cell lung carcinoma: Analysis of the function of SMAD3 using GSEA showed that high SMAD3 expression was related to multiple types of cancer including NSCLC, and cancer-related pathways such as PI3K/Akt/mTOR and KRAS (Fig. 4A, B).